Normal view MARC view ISBD view

Pouessel, Damien

Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel. [electronic resource] - Expert review of anticancer therapy Dec 2006 - 1761-7 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-8328

Standard No.: 10.1586/14737140.6.12.1761 doi

Subjects--Topical Terms:
Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Benzenesulfonates--therapeutic use
Bevacizumab
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Drug Delivery Systems
Drug Therapy, Combination
Forecasting
Humans
Immunologic Factors--therapeutic use
Immunotherapy
Indoles--therapeutic use
Interferon-alpha--administration & dosage
Interleukin-2--administration & dosage
Kidney Neoplasms--therapy
Neoplasm Proteins--antagonists & inhibitors
Niacinamide--analogs & derivatives
Phenylurea Compounds
Protein Kinase Inhibitors--therapeutic use
Protein Kinases--drug effects
Pyridines--therapeutic use
Pyrroles--therapeutic use
Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors
Sirolimus--analogs & derivatives
Sorafenib
Sunitinib
TOR Serine-Threonine Kinases